AI assistant
Sending…
IONIC RARE EARTHS LIMITED — Director's Dealing 2017
Jun 21, 2017
65151_rns_2017-06-21_495f8044-9391-428d-ab8a-9f3c5bba1d8e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Appendix 3Y
Change of Director’s Interest Notice
Name of entity ORO VERDE LIMITED ABN 84 083 646 477
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | DR WOLF GERHARD MARTINICK |
|---|---|
| Date of last notice | 17 January 2017 |
Part 1 - Change of director’s relevant interests in securities
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest | Dr Martinick is a director of Martinick |
| (including registered holder) | Investments Pty Ltd and a beneficiary of the |
| Martinick Superannuation Fund of which | |
| Martinick Investments is a trustee | |
| Date of change | 20 June 2017 |
| No. of securities held prior to change | Direct – 7,956,021 |
| Indirect - 43,000,000 fully paid shares | |
| Class | Fully paid ordinary shares |
| Number acquired | 238,318 |
| Number disposed | - |
| Value/Consideration | $5,100 |
| No. of securities held after change | Direct – 8,194,339 |
| Indirect - 43,000,000 fully paid shares | |
| Nature of changes | Participation in the Company’s Directors |
| Share Plan approved by shareholders at the | |
| 2016 AGM |
Part 2 – Change of director’s interests in contracts
NIL
Part 3 – Closed period
| NILPart 3 – Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a closed period where prior writtenclearance was required? | No |
| If so, was prior written clearance provided to allow the tradeto proceed during this period? | N/A |
| If prior written clearance was provided, on what date was thisprovided? | N/A |
More from IONIC RARE EARTHS LIMITED
Share Issue/Capital Change
2026
May 28
Share Issue/Capital Change
2026
May 28
Share Issue/Capital Change
2026
May 28
Share Issue/Capital Change
2026
May 27
Regulatory Filings
2026
May 24
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 10
Investor Presentation
2026
May 5
Investor Presentation
2026
May 5
Investor Presentation
2026
May 3